141 related articles for article (PubMed ID: 8101959)
21. Comparison of bromodeoxyuridine and proliferating cell nuclear antigen labeling in gastric carcinoma.
Kang SM; Kim WH; Kim CW; Kim YI
J Korean Med Sci; 1994 Feb; 9(1):16-20. PubMed ID: 7915118
[TBL] [Abstract][Full Text] [Related]
22. [Nuclear DNA ploidy pattern and proliferating cell nuclear antigen labeling index in gastric cancer with mucosal involvement].
Maeda K; Chung YS; Kubo T; Nishimura M; Onoda N; Nitta A; Arimoto Y; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():58-61. PubMed ID: 7911294
[TBL] [Abstract][Full Text] [Related]
23. Histopathological response to preoperative chemotherapy including 5-fluorouracil additionally assessed by immunocytochemical and pharmacologic parameters in patients with advanced gastric cancer.
Nakano H; Namatame K; Suzuki T; Takahashi H; Sakai H; Nakamura T; Kumada K
Surg Today; 1996; 26(7):482-8. PubMed ID: 8840428
[TBL] [Abstract][Full Text] [Related]
24. [Study of proliferating cell nuclear antigen (PCNA), nucleolar organizer regions (NORs) and mitotic activity in epithelial ovarian tumors].
Yamanaka S; Nagai N; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Mar; 45(3):234-40. PubMed ID: 8098347
[TBL] [Abstract][Full Text] [Related]
25. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
26. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.
Zeymer U; Fishbein MC; Forrester JS; Cercek B
Am J Pathol; 1992 Sep; 141(3):685-90. PubMed ID: 1381560
[TBL] [Abstract][Full Text] [Related]
27. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
Steck K; el-Naggar AK
Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
29. Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area.
Wang LD; Zhou Q; Yang CS
J Cell Biochem Suppl; 1997; 28-29():159-65. PubMed ID: 9589362
[TBL] [Abstract][Full Text] [Related]
30. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
Risio M; Candelaresi G; Rossini FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
[TBL] [Abstract][Full Text] [Related]
31. Delay in fixation does not affect the immunoreactivity of proliferating cell nuclear antigen (PCNA).
Start RD; Cross SS; Clelland C; Silcocks PB; Rogers K; Smith JH
J Pathol; 1992 Oct; 168(2):197-9. PubMed ID: 1361001
[TBL] [Abstract][Full Text] [Related]
32. Proliferative activity of gastric cancer assessed by immunostaining for proliferating cell nuclear antigen.
Inada T; Imura J; Ichikawa A; Ogata Y; Shimamura K
J Surg Oncol; 1993 Nov; 54(3):146-51; discussion 151-2. PubMed ID: 8105151
[TBL] [Abstract][Full Text] [Related]
33. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.
Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M
Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer.
Mori M; Kakeji Y; Adachi Y; Moriguchi S; Maehara Y; Sugimachi K; Jessup JM; Chen LB; Steele GD
Surgery; 1993 Jun; 113(6):683-90. PubMed ID: 8099452
[TBL] [Abstract][Full Text] [Related]
35. Analysis of proliferative activity using anti-proliferating cell nuclear antigen antibody in gastric cancer tissue specimens obtained by endoscopic biopsy.
Yonemura Y; Kimura H; Fushida S; Tugawa K; Nakai Y; Kaji M; Fonseca L; Yamaguchi A; Miyazaki I
Cancer; 1993 Apr; 71(8):2448-53. PubMed ID: 8095851
[TBL] [Abstract][Full Text] [Related]
36. [Flow cytometric techniques for measurement of proliferating cell nuclear antigen (PCNA)].
Ichikawa A; Shimamura K; Koyama Y
Nihon Rinsho; 1992 Oct; 50(10):2343-8. PubMed ID: 1360029
[TBL] [Abstract][Full Text] [Related]
37. Giant cell tumor of bone: analysis of proliferative cells by double-labeling immunohistochemistry with anti-proliferating cell nuclear antigen antibody and culture procedure.
Abe Y; Yonemura K; Nishida K; Takagi K
Nihon Seikeigeka Gakkai Zasshi; 1994 May; 68(5):407-14. PubMed ID: 7914219
[TBL] [Abstract][Full Text] [Related]
38. Prognostic evaluation of curatively resected locally advanced gastric cancer patients with preoperative downstaging chemotherapy assessed by histochemical and pharmacologic means.
Nakano H; Namatame K; Suzuki T; Kim J; Sasaki J; Nagasaki H; Makuuchi M; Kumada K
Oncology; 1995; 52(6):474-82. PubMed ID: 7478434
[TBL] [Abstract][Full Text] [Related]
39. Quantification of hepatocytic proliferation in the laboratory mouse. A comparative study using immunohistochemical detection of bromodeoxyuridine (BrdU) incorporation and proliferating cell nuclear antigen (PCNA) expression.
Lardelli P; Perentes E; Meier G; Navarro N; Ettlin RA
Exp Toxicol Pathol; 1994 Jul; 46(2):95-100. PubMed ID: 7987078
[TBL] [Abstract][Full Text] [Related]
40. [Expression of proliferation associated nuclear antigen P-105 in human gastric cancers: as a new marker for metastasis].
Oyama S; Yonemura Y; Tsugawa K; Kimura Y; Kamata T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):303-7. PubMed ID: 1675758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
